4.7 Review

Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

期刊

NATURE REVIEWS CANCER
卷 9, 期 9, 页码 615-630

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2695

关键词

-

类别

资金

  1. US National Institutes of Health [R01DK058242, R01CA112403, R01CA119689, P01DK059820, R01HD07857, R01HD08818]
  2. National Institute of Diabetes and Digestive
  3. American Cancer Society Research Scholar Award [RSG-05-082-01]
  4. Susan Komen for the Cure Award [BCTR0707225]
  5. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD008188, R01HD007857] Funding Source: NIH RePORTER
  6. NATIONAL CANCER INSTITUTE [R01CA119689, R01CA112403] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, R01DK058242] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The three homologous members of the p160 SRC family (SRC1, SRC2 and SRC3) mediate the transcriptional functions of nuclear receptors and other transcription factors, and are the most studied of all the transcriptional co-activators. Recent work has indicated that the SRC genes are subject to amplification and overexpression in various human cancers. Some of the molecular mechanisms responsible for SRC overexpression, along with the mechanisms by which SRCs promote breast and prostate cancer cell proliferation and survival, have been identified, as have the specific contributions of individual SRC family members to spontaneous breast and prostate carcinogenesis in genetically manipulated mouse models. These studies have identified new challenges for cancer research and therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据